Bandaram Pharma Packtech AGM and Financial Update

Consolidated Revenue rose to Rs 6292.32 lakh in FY 2026 from Rs 3696.37 lakh in FY 2025. Consolidated Net Profit dropped to Rs 28.12 lakh from Rs 99.38 lakh during the same period.

Reader Takeaway: Revenue growth is tempered by falling profitability and significant auditor concerns regarding subsidiary accounting practices.

What just happened

Bandaram Pharma Packtech Ltd will hold its Annual General Meeting on September 24, 2026, via video conferencing. The company also disclosed consolidated financial results showing increased top-line growth but declining net margins. Additionally, the company integrated Craftsmart Products Private Limited as a wholly-owned subsidiary following a share allotment in November 2025.

Why this matters

The auditor's qualified opinion on the consolidated statements is a critical point for shareholders. The auditor flagged that subsidiary VSR Paper and Packaging Ltd netted off trade receivables and payables by Rs 1240.80 lakh without sufficient documentation. This practice has led to an understatement of both sundry debtors and creditors, raising concerns regarding accounting oversight.

Board and Management Changes

The company has experienced significant turnover in its leadership. Several directors, including multiple Independent Directors and one Whole-time Director, resigned during the fiscal year. New appointments include Mr. Eswar Reddy Putturu and Mrs. Mounika Pammi as Independent Directors.

What to track next

Investors should monitor the upcoming AGM discussions regarding the qualified audit opinion and management's strategy to address the subsidiary's accounting discrepancies. The focus remains on how the company plans to restore consolidated profitability and ensure governance stability following recent board resignations.